The Novel TB Vaccines Preparedness Consortium recently convened in Johannesburg, South Africa, bringing together leading researchers, policymakers, and partner organisations to ensure South Africa is ready to introduce new TB vaccines as soon as they become available.
Prof Lee Fairlie, director of Maternal and Child Health at Wits RHI, opened the meeting by framing the purpose of the consortium: “Our goal is to ensure that when new TB vaccines are licensed, we are ready to hit the ground running – quickly and efficiently.” With clinical trials showing promise, the consortium is working to identify gaps, strengthen health systems, and ensure equitable access to these future vaccines.
Prof Limakatso Lebina, AHRI’s director for clinical trials, shared the consortium’s vision and mission: “We aim to accelerate the introduction and equitable delivery of novel TB vaccines in South Africa by convening a consortium of academic researchers and policymakers. Our objectives include securing funding and ensuring timely completion of consortium projects.”
Prof Willem Hanekom, AHRI’s executive director, highlighted the importance of innovation and collaboration: “We need to set up demonstration projects today that will prepare us for vaccine roll-out tomorrow. At the same time, we must create awareness and strengthen community confidence to counter vaccine hesitancy.”
The meeting reflected the strength of collaboration across multiple organisations, with participants contributing diverse expertise on clinical research, health systems, community engagement, and policy. Key discussions focused on:
- Addressing gaps in population groups included in TB vaccine studies.
- Building communication strategies that engage communities and address vaccine confidence.
- Strengthening health systems and identifying demonstration sites.
- Securing sustainable financing through dedicated task teams.
As the consortium looks ahead, it will continue shaping strategies for research, policy, and implementation, with the next meeting planned for January 2026.
By uniting organisations and expertise, the consortium is laying the groundwork to ensure that when new TB vaccines arrive, South Africa is ready.